BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31263411)

  • 1.
    Ludwig FA; Fischer S; Houska R; Hoepping A; Deuther-Conrad W; Schepmann D; Patt M; Meyer PM; Hesse S; Becker GA; Zientek FR; Steinbach J; Wünsch B; Sabri O; Brust P
    Front Pharmacol; 2019; 10():534. PubMed ID: 31263411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of σ receptors: synthesis and evaluation of the potent σ1 selective radioligand [18F]fluspidine.
    Fischer S; Wiese C; Maestrup EG; Hiller A; Deuther-Conrad W; Scheunemann M; Schepmann D; Steinbach J; Wünsch B; Brust P
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):540-51. PubMed ID: 21072511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors.
    Ludwig FA; Smits R; Fischer S; Donat CK; Hoepping A; Brust P; Steinbach J
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27617996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in Silico, Electrochemical, in Vitro and in Vivo Metabolism of a Homologous Series of (Radio)fluorinated σ
    Wiese C; Große Maestrup E; Galla F; Schepmann D; Hiller A; Fischer S; Ludwig FA; Deuther-Conrad W; Donat CK; Brust P; Büter L; Karst U; Wünsch B
    ChemMedChem; 2016 Nov; 11(21):2445-2458. PubMed ID: 27677767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Metabolism of (+)-[
    Ludwig FA; Fischer S; Smits R; Deuther-Conrad W; Hoepping A; Tiepolt S; Patt M; Sabri O; Brust P
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29461507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.
    Peyronneau MA; Saba W; Goutal S; Damont A; Dollé F; Kassiou M; Bottlaender M; Valette H
    Drug Metab Dispos; 2013 Jan; 41(1):122-31. PubMed ID: 23065531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(18)F]Fallypride: metabolism studies and quantification of the radiotracer and its radiometabolites in plasma using a simple and rapid solid-phase extraction method.
    Peyronneau MA; Saba W; Goutal S; Kuhnast B; Dollé F; Bottlaender M; Valette H
    Nucl Med Biol; 2013 Oct; 40(7):887-95. PubMed ID: 23891202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: part II: Metabolism studies.
    Peyronneau MA; Saba W; Dollé F; Goutal S; Coulon C; Bottlaender M; Valette H
    Nucl Med Biol; 2012 Apr; 39(3):347-59. PubMed ID: 22154687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive in vivo kinetics of the new σ1 receptor ligands (R)-(+)- and (S)-(-)-18F-fluspidine in porcine brain.
    Brust P; Deuther-Conrad W; Becker G; Patt M; Donat CK; Stittsworth S; Fischer S; Hiller A; Wenzel B; Dukic-Stefanovic S; Hesse S; Steinbach J; Wünsch B; Lever SZ; Sabri O
    J Nucl Med; 2014 Oct; 55(10):1730-6. PubMed ID: 25071097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Ludwig FA; Laurini E; Schmidt J; Pricl S; Deuther-Conrad W; Wünsch B
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of σ₁ Receptors.
    Kranz M; Sattler B; Wüst N; Deuther-Conrad W; Patt M; Meyer PM; Fischer S; Donat CK; Wünsch B; Hesse S; Steinbach J; Brust P; Sabri O
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27598110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.
    Schou M; Zoghbi SS; Shetty HU; Shchukin E; Liow JS; Hong J; Andrée BA; Gulyás B; Farde L; Innis RB; Pike VW; Halldin C
    Mol Imaging Biol; 2009; 11(1):23-30. PubMed ID: 18800204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [
    Eberl S; Katsifis A; Peyronneau MA; Wen L; Henderson D; Loc'h C; Greguric I; Verschuer J; Pham T; Lam P; Mattner F; Mohamed A; Fulham MJ
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):296-307. PubMed ID: 27699720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiodefluorination of 3-fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with positron emission tomography, occurs by glutathionylation in rat brain.
    Shetty HU; Zoghbi SS; Siméon FG; Liow JS; Brown AK; Kannan P; Innis RB; Pike VW
    J Pharmacol Exp Ther; 2008 Dec; 327(3):727-35. PubMed ID: 18806125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [
    Schou M; Amini N; Takano A; Arakawa R; Dahl K; Toth M; Svedberg M; Varrone A; Halldin C
    ACS Chem Neurosci; 2023 Oct; 14(20):3732-3736. PubMed ID: 37753876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [11C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET).
    Gourand F; Amini N; Jia Z; Stone-Elander S; Guilloteau D; Barré L; Halldin C
    PLoS One; 2015; 10(9):e0137160. PubMed ID: 26367261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C]flumazenil, [18F]FE-PE2I, and [11C]PBR28.
    Amini N; Nakao R; Schou M; Halldin C
    Anal Bioanal Chem; 2013 Feb; 405(4):1303-10. PubMed ID: 23180082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.
    Sorger D; Becker GA; Patt M; Schildan A; Grossmann U; Schliebs R; Seese A; Kendziorra K; Kluge M; Brust P; Mukhin AG; Sabri O
    Nucl Med Biol; 2007 Apr; 34(3):331-42. PubMed ID: 17383583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
    Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
    Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
    Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.